Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-26 @ 2:11 AM
Study NCT ID:
NCT04016805
Status:
TERMINATED
Last Update Posted:
2023-07-24
First Post:
2019-07-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Assess the Efficacy and Safety of Ublituximab and Umbralisib in Participants With Chronic Lymphocytic Leukemia (CLL) Currently Treated With Ibrutinib, Acalabrutinib or Venetoclax
Sponsor:
TG Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-05
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-22
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-10
First Submit QC Date:
None
Study First Post Date:
2019-07-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-05-18
Results First Submit QC Date:
None
Results First Post Date:
2023-07-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-03
Last Update Post Date:
2023-07-24
Last Update Post Date Type:
ACTUAL